4.7 Article

Critical roles for c-Myb in lymphoid priming and early B-cell development

期刊

BLOOD
卷 115, 期 14, 页码 2796-2805

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2009-08-239210

关键词

-

资金

  1. National Health and Medical Research Council (NHMRC) of Australia
  2. National Heart, Lung, and Blood Institute [R01 HL080019]
  3. Pfizer Australia Research Fellowship
  4. NHMRC
  5. Australian Research Council
  6. Leukemia Foundation of Australia
  7. University of Melbourne
  8. MRC [G0501688] Funding Source: UKRI
  9. Medical Research Council [G9818340B, G0501688] Funding Source: researchfish

向作者/读者索取更多资源

c-Myb is a transcription factor with functions in many hematopoietic lineages. c-Myb-deficient mice display reduced numbers of B cells; however, it is unknown what role c-Myb plays in B lymphopoiesis because no critical target genes have been identified in the B-cell lineage. We demonstrate that conditional deletion of c-Myb in B-cell progenitors completely abolishes B-cell development. c-Myb is required for lymphoid progenitors to respond to the cytokines interleukin-7 and thymic stromal lymphopoietin; in the absence of sufficient c-Myb activity, mice display a B lymphopenia that closely resembles that observed in interleukin-7 receptor alpha-deficient animals. Analysis of the multipotent progenitor compartment indicates that c-Myb is also required for up-regulation of multiple lymphoidassociated genes, including Il7r, and for the subsequent development of the common lymphoid progenitor population. These data show that c-Myb plays a critical role in the regulatory pathways governing lymphoid specification and early B-cell differentiation. (Blood. 2010; 115(14): 2796-2805)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据